Diabetes, hepatitis virus infection and hepatocellular carcinoma: A case-control study in hepatitis endemic area

Hepatology Research

Volumn 42, Issue 8, 2012, Pages 774-781

  Ko, Wei Hsu ^a   Chiu, Sherry Yueh Hsia ^d   Yang, Kuo Ching ^a,b   Chen, Hsiu Hsi ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Synergistic effect

Indexed keywords

GLUCOSE; HYPERGLYCEMIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFECTION RISK; INSULIN TREATMENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84863749909     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.00979.x     Document Type: Article

References (22)

1. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-80.
2. Lai MS, Hsieh MS, Chiu YH etal. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43: 1295-302.
3. Chen CL, Yang HI, Yang WS etal. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
4. Wang CS, Yao WJ, Chang TT etal. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009; 18: 2054-60.
5. Lu SN, Lin TM, Chen CJ etal. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988; 62: 2051-5.
6. Tung HD, Wang JH, Tseng PL etal. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies. Am J Gastroenterol 2010; 105: 624-31.
7. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1): S5-20.
8. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott, 1998.
9. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992; 3: 452-6.
10. Bruzzi P, Green SB, Byar DP etal. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985; 122: 904-14.
11. SAS Institute Inc. SAS/STAT® Version 9.1. Cary, NC: SAS Institute Inc., 2007.
12. Wang CS, Wang ST, Yao WJ etal. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol 2003; 158: 1154-60.
13. Wang CS, Wang ST, Yao WJ etal. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol 2007; 166: 196-203.
14. Huang JF, Dai CY, Hwang SJ etal. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol 2007; 102: 1237-43.
15. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9: 531-941.
16. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987; 71-80.
17. Chen DS, Kuo GC, Sung JL etal. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817-22.
18. Chen CH, Yang PM, Huang GT etal. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007; 106: 148-55.
19. Chou P, Li CL, Tsai ST. Epidemiology of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2001; 54: S29-35.
20. Kawaguchi T, Taniguchi E, Morita Y etal. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int 2010; 30: 479-86.
21. Donadon V, Balbi M, Ghersetti M etal. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol 2009; 15: 2506-11.
22. Giovannucci E, Harlan DM, Archer MC etal. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85.